Sofosbuvir Containing Regimens in Treatment of COVID 19 Patients

NCT04497649 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: Sofosbuvir
DRUG: Daclatasvir

Sponsor

Tanta University